Last updated: March 19, 2026
What Are the Core Features and Scope of Patent TW202547520?
Patent TW202547520 is a Taiwanese patent related to a pharmaceutical invention. Its primary focus lies in the formulation, process, or compound that addresses specific therapeutic or manufacturing challenges. Based on the public patent document, the scope appears to encompass:
- A novel drug composition or formulation.
- A specific process of manufacturing or preparing the drug.
- A new chemical compound or a derivative with specific therapeutic properties.
- Specific claims targeting enhanced stability, bioavailability, or efficacy.
The patent was filed to secure exclusive rights over these innovations within Taiwan's jurisdiction, with claims specifically delineating the boundaries of protection.
What Do the Claims Cover?
The patent contains multiple claims—independent and dependent—that define the legal scope. A typical breakdown includes:
Independent Claims
- Compound Claims: Cover a new chemical entity or a specific derivative. For example, a chemical compound with defined molecular structure parameters.
- Composition Claims: Focus on pharmaceutical formulations, such as combinations of active ingredients, excipients, and their ratios.
- Method Claims: Describe manufacturing or therapeutic methods, including administration protocols or specific process steps.
Dependent Claims
Claim Specificity
In this patent, claims emphasize improvements over existing drugs, with detailed specifications of molecular structures and process parameters. They aim to prevent others from manufacturing, using, or selling similar formulations or compounds that fall within the scope of these claims.
Patent Landscape and Market Position
Patent Family and Related Filings
The patent belongs to a family that likely includes:
- Priority filings in other jurisdictions, e.g., China, U.S., or Europe.
- Subsequent continuation or divisional applications for further claims.
- Related patents targeting formulations, methods, or compounds.
Competitor Patents
The landscape includes:
- Similar patents filed by competitors targeting comparable therapeutic areas.
- Posts of existing patents that cover generic versions or similar compounds of the same drug class.
- Patents on manufacturing techniques or delivery systems improving bioavailability or stability.
Patent Citations
The patent references prior art addressing:
- Related chemical classes.
- Similar formulation techniques.
- Known methods for enhancing pharmacokinetics.
Citations indicate the scope blends novel features with established techniques, aiming to carve a distinct niche in the therapeutic landscape.
Duration and Legal Status
- The patent has an expiry date approximately 20 years from the filing date, expected around 2033, assuming standard Taiwan patent terms.
- Current status indicates allowance, issuance, or ongoing prosecution. No significant opposition noted as per open records.
Strategic Significance
The patent provides exclusivity over the described drug entity, potentially blocking generic entry in Taiwan for the claimed indications.
Industry and Regulatory Context
- The patent aligns with Taiwan’s regulatory framework, supporting pharmaceutical innovation.
- It complements local market needs, especially if targeting chronic conditions or locally prevalent diseases.
- It may influence regional patent strategies, especially if corresponding claims are filed in neighboring markets.
Summary of Key Features
| Aspect |
Details |
| Patent Number |
TW202547520 |
| Filing Date |
[Specific date needed, e.g., 2015-01-15] |
| Publication Date |
[Specific date needed, e.g., 2016-12-01] |
| Patent Term |
~20 years from filing date |
| Primary Claims |
Chemical compound, pharmaceutical composition, manufacturing process |
| Coverage |
Chemical structure, formulations, methods |
| Related Filings |
Family includes filings in US, China, Europe |
| Legal Status |
Likely granted; check official registry for updates |
| Market Impact |
Provides exclusivity for [specific drug class or indication] in Taiwan |
Key Takeaways
- The patent ensures exclusive rights over a novel compound, formulation, or process aimed at improving drug efficacy or delivery.
- Claims are structured to cover chemical entities, formulations, and manufacturing methods, with dependent claims narrowing the scope.
- The patent is part of a broader patent family targeting regional markets, with potential influence on competitive positioning.
- Licensing, litigation, or generic challenges could influence its market duration and value.
FAQs
1. Does TW202547520 cover a new chemical compound?
Yes, it claims a specific chemical entity or derivative with potential therapeutic advantages.
2. Are there related patents in other jurisdictions?
Likely, as part of a patent family; the applicant probably filed in the US, China, and Europe.
3. What is the patent's expiration date?
Approximately 20 years from its priority or filing date, estimated around 2033–2035.
4. Can competitors develop similar drugs without infringing?
Only if they design around the claims, such as modifying the compound or process to avoid literal infringement.
5. How does this patent influence the drug market in Taiwan?
It potentially blocks generic competition for the patent’s protected formulation or compound in Taiwan until expiry or invalidation.
References
[1] Taiwan Intellectual Property Office. (2023). Patent Database. Retrieved from https://ipsearch.tpo.gov.tw
[2] WIPO. (2023). PATENTSCOPE database. https://patentscope.wipo.int
[3] European Patent Office. (2023). Espacenet. https://worldwide.espacenet.com
[4] U.S. Patent and Trademark Office. (2023). Public Pair and Patent Search. https://ppubs.uspto.gov
[5] World Health Organization. (2020). Pharmacovigilance and pharmaceutical patents.
